Bank of Hawaii’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,378
Closed -$1.72M 226
2025
Q4
$1.72M Buy
9,378
+598
+7% +$105K 0.09% 101
2025
Q3
$1.35M Buy
8,780
+649
+8% +$98.2K 0.07% 118
2025
Q2
$1.14M Buy
8,131
+2,558
+46% +$359K 0.06% 124
2025
Q1
$819K Buy
5,573
+1,302
+30% +$188K 0.05% 138
2024
Q4
$560K Sell
4,271
-273
-6% -$38.2K 0.03% 170
2024
Q3
$708K Sell
4,544
-668
-13% -$108K 0.03% 162
2024
Q2
$813K Sell
5,212
-171
-3% -$25.7K 0.04% 146
2024
Q1
$729K Sell
5,383
-985
-15% -$130K 0.04% 163
2023
Q4
$858K Sell
6,368
-1,565
-20% -$203K 0.05% 142
2023
Q3
$1.07M Buy
7,933
+777
+11% +$106K 0.06% 126
2023
Q2
$1.02M Buy
7,156
+285
+4% +$41.9K 0.06% 129
2023
Q1
$954K Buy
6,871
+1,347
+24% +$181K 0.06% 139
2022
Q4
$749K Sell
5,524
-2,197
-28% -$276K 0.05% 147
2022
Q3
$847K Sell
7,721
-5,921
-43% -$751K 0.06% 128
2022
Q2
$1.8M Sell
13,642
-1,028
-7% -$135K 0.11% 88
2022
Q1
$1.95M Buy
14,670
+14
+0.1% +$1.68K 0.11% 91
2021
Q4
$1.71M Sell
14,656
-73
-0.5% -$8.59K 0.09% 100
2021
Q3
$1.77M Sell
14,729
-274
-2% -$31.9K 0.1% 94
2021
Q2
$1.8M Sell
15,003
-1,457
-9% -$160K 0.1% 101
2021
Q1
$1.64M Sell
16,460
-432
-3% -$43.4K 0.1% 104
2020
Q4
$1.69M Sell
16,892
-3,132
-16% -$332K 0.11% 98
2020
Q3
$2.19M Sell
20,024
-1,590
-7% -$177K 0.16% 84
2020
Q2
$2.29M Sell
21,614
-5,219
-19% -$539K 0.17% 75
2020
Q1
$2.4M Sell
26,833
-1,118
-4% -$105K 0.21% 64
2019
Q4
$2.79M Sell
27,951
-989
-3% -$93.1K 0.19% 67
2019
Q3
$2.58M Sell
28,940
-922
-3% -$79.9K 0.19% 75
2019
Q2
$2.46M Sell
29,862
-7,950
-21% -$623K 0.18% 81
2019
Q1
$3.06M Sell
37,812
-4,250
-10% -$335K 0.23% 65
2018
Q4
$3.19M Sell
42,062
-4,358
-9% -$340K 0.28% 58
2018
Q3
$3.67M Sell
46,420
-2,740
-6% -$207K 0.28% 60
2018
Q2
$3.45M Sell
49,160
-135
-0.3% -$9.71K 0.29% 61
2018
Q1
$3.45M Buy
49,295
+440
+0.9% +$30.5K 0.29% 61
2017
Q4
$3.39M Buy
48,855
+1,067
+2% +$72K 0.28% 70
2017
Q3
$3.24M Sell
47,788
-6,592
-12% -$416K 0.27% 74
2017
Q2
$3.71M Buy
54,380
+2,736
+5% +$179K 0.32% 59
2017
Q1
$3.22M Buy
51,644
+8,410
+19% +$490K 0.29% 70
2016
Q4
$2.36M Buy
43,234
+24,848
+135% +$1.41M 0.22% 85
2016
Q3
$1.21M Buy
18,386
+4,450
+32% +$291K 0.11% 132
2016
Q2
$841K Buy
13,936
+3,201
+30% +$186K 0.09% 174
2016
Q1
$605K Buy
10,735
+3,522
+49% +$212K 0.07% 204
2015
Q4
$490K Buy
+7,213
New +$473K 0.06% 249
2014
Q4
Sell
-7,337
Closed -$524K 361
2014
Q3
$524K Sell
7,337
-1,342
-15% -$98.2K 0.05% 241
2014
Q2
$645K Sell
8,679
-134,737
-94% -$9.74M 0.06% 235
2014
Q1
$9.3M Sell
143,416
-2,952
-2% -$191K 0.93% 18
2013
Q4
$8.69M Sell
146,368
-6,482
-4% -$352K 0.88% 24
2013
Q3
$7.94M Buy
152,850
+2,320
+2% +$117K 0.83% 26
2013
Q2
$7.12M Buy
+150,530
New +$7.67M 0.77% 34

Other funds holding AZN

Bank of Hawaii's AZN Position: Q1 2026 in Review

Bank of Hawaii sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 9,378 shares — an estimated $1.72M sold.

Bank of Hawaii first reported a position in AZN in Q2 2013 and held it in 47 quarters. The position peaked at $9.3M in Q1 2014. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Bank of Hawaii reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Bank of Hawaii sold 9,378 AstraZeneca shares in Q1 2026, an estimated $1.72M.
  • Bank of Hawaii first reported a position in AstraZeneca in Q2 2013 and held it in 47 quarters.
  • Bank of Hawaii's AstraZeneca position peaked at $9.3M in Q1 2014.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.